We are live on
!
Find out more
KA
Kintegral Advisory Portfolio holdings
AUM
$1.06B
1-Year Est. Return
24.93%
This Fund
S&P 500
This Quarter
Est. Return
+10.75%
1 Year Est. Return
+24.93%
3 Year Est. Return
+94.38%
5 Year Est. Return
+128.14%
10 Year Est. Return
–
AUM
$550M
AUM Growth
+$47.8M
(+9.5%)
Cap. Flow
-$677K
Cap. Flow
% of AUM
-0.12%
Top 10 Holdings %
Top 10 Hldgs %
28.86%
Holding
269
New
1
Increased
2
Reduced
1
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$991K |
| 2 |
Truist Financial
TFC
|
+$326K |
| 3 |
BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
|
+$45K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.72M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$320K |
| 3 |
3M
MMM
|
+$560 |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.68% |
| 2 | Healthcare | 14.72% |
| 3 | Financials | 13.9% |
| 4 | Communication Services | 10.73% |
| 5 | Consumer Staples | 7.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
JPMorgan Chase
JPM
$923B
| $4.82M | 0.88% |
34,591
| – | – |
|
27
Agilent Technologies
A
$39.2B
| $4.67M | 0.85% |
54,629
| – | – |
|
28
Adobe
ADBE
$84.6B
| $4.62M | 0.84% |
14,003
| – | – |
|
29
Zoetis
ZTS
$31B
| $4.38M | 0.8% |
33,130
| – | – |
|
30
Prologis
PLD
$136B
| $4.38M | 0.8% |
49,185
| – | – |
|
31
AbbVie
ABBV
$452B
| $4.16M | 0.76% |
46,962
| – | – |
|
32
Northern Trust
NTRS
$21.9B
| $4.15M | 0.76% |
38,837
| – | – |
|
33
Johnson & Johnson
JNJ
$622B
| $4.03M | 0.73% |
27,635
| – | – |
|
34
American Tower
AMT
$76.7B
| $3.95M | 0.72% |
17,130
| – | – |
|
35
McDonald's
MCD
$186B
| $3.79M | 0.69% |
19,187
| – | – |
|
|
36
Bristol-Myers Squibb
BMY
$126B
| $3.71M | 0.67% |
57,807
+17,299
| +43% | +$991K |
|
37
Caterpillar
CAT
$413B
| $3.67M | 0.67% |
24,854
| – | – |
|
38
Visa
V
$666B
| $3.47M | 0.63% |
18,461
| – | – |
|
|
TIF
39
DELISTED
Tiffany & Co.
TIF
| $3.38M | 0.61% |
25,169
| – | – |
|
40
Union Pacific
UNP
$181B
| $3.37M | 0.61% |
18,610
| – | – |
|
41
IBM
IBM
$191B
| $3.34M | 0.61% |
26,042
| – | – |
|
42
Bank of America
BAC
$429B
| $3.33M | 0.61% |
94,598
| – | – |
|
43
Cummins
CMI
$91.8B
| $3.21M | 0.58% |
17,956
| – | – |
|
44
Johnson Controls International
JCI
$87.6B
| $3.19M | 0.58% |
77,862
| – | – |
|
45
Sempra
SRE
$61.1B
| $3.18M | 0.58% |
41,664
| – | – |
|
46
Best Buy
BBY
$17.7B
| $3.1M | 0.56% |
35,165
| – | – |
|
|
K
47
DELISTED
Kellanova
K
| $3.01M | 0.55% |
46,337
| – | – |
|
48
Linde
LIN
$234B
| $2.98M | 0.54% |
14,022
| – | – |
|
49
Starbucks
SBUX
$118B
| $2.92M | 0.53% |
33,216
| – | – |
|
50
Applied Materials
AMAT
$443B
| $2.88M | 0.52% |
47,199
| – | – |
|
Similar funds
MWA
SFP
CA
MFS
ECM
NRG
HW
LAM
Kintegral Advisory's Q4 2019 Portfolio in Review
As of Q4 2019, Kintegral Advisory held 269 positions worth $550M, up 9.5% from $502M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 1.1%. Kintegral Advisory opened 1 new position and exited 2, leaving the 269-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
- Kintegral Advisory's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 17,299 shares worth $52K.
- Kintegral Advisory added most to Bristol-Myers Squibb in Q4 2019, an estimated $991K increase.
- Kintegral Advisory's biggest Q4 2019 reduction was 3M, cutting an estimated $560.
- Kintegral Advisory fully exited Celgene Corp in Q4 2019, selling an estimated $1.72M.
- Kintegral Advisory's ten largest holdings make up 29% of its $550M portfolio in Q4 2019.
- Kintegral Advisory opened 1 new position and closed 2 in Q4 2019.
- Kintegral Advisory's portfolio value rose 9.5% quarter-over-quarter to $550M.
Based on Kintegral Advisory's 13F filing for Q4 2019, filed 10 Feb 2020.